GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » 5-Year EBITDA Growth Rate

Cannabist Company Holdings (NEOE:CBST) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings 5-Year EBITDA Growth Rate?

Cannabist Company Holdings's EBITDA per Share for the three months ended in Dec. 2024 was C$-0.09.

During the past 12 months, Cannabist Company Holdings's average EBITDA Per Share Growth Rate was -38.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Cannabist Company Holdings's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's 5-Year EBITDA Growth Rate falls into.


;
;

Cannabist Company Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Cannabist Company Holdings  (NEOE:CBST) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Cannabist Company Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Executives
David Sirolly Senior Officer
Julie Anne Hill Director
Jesse Channon Senior Officer
David Hart Senior Officer
Derek Alan Watson Senior Officer
Jeffrey James Clarke Director
Alison Worthington Director
Nicholas Keane Vita 10% Security Holder, Director
Bryan Lamont Olson Senior Officer
Michael James Abbott 10% Security Holder, Director

Cannabist Company Holdings Headlines

No Headlines